Article

Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.

2024-03-25

Abstract excerpt

<title>Abstract</title> <p><bold>Objectives</bold> The Revised international prognostic scoring system (IPSS-R) is now commonly being used clinically to guide the treatment of myelodysplastic neoplasms (MDS). Recently, the Molecular International Prognostic Scoring System (IPSS-M)was proposed. In this study, we have validated the potential predictive value of the comparative IPSS-M in Chinese MDS patients. <bold>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 090771ac-d954-5054-938a-c02861611bb8
DOI: 10.21203/rs.3.rs-4129078/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.DOI 10.21203/rs.3.rs-4129078/v1Read

Validation of the Molecular International Prognostic Scoring System in Patients with Myelodysplastic Syndromes Defined by International Consensus ClassificationSemantic proximity Read

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.Semantic proximity Read

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.Semantic proximity Read

A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS.Semantic proximity Read

When to use which molecular prognostic scoring system in the management of patients with MDS?Semantic proximity Read

[Molecular international prognostic scoring system for myelodysplastic syndromes].Semantic proximity Read

Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.Semantic proximity Read

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.Semantic proximity Read

Prognostic models in myelodysplastic syndromes.Semantic proximity Read

Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication.Semantic proximity Read

Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.Semantic proximity Read

Impact of the International Consensus Classification of myelodysplastic syndromes.Semantic proximity Read